Joint Stock
The Joint Corp.
Company data
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Country
- United States
- CEO
- Sanjiv Razdan
- Employees
- 330
- Market cap
- $99 M
- IPO
- 11/11/2014
The Joint Corp. specializes in the establishment, proprietorship, operation, and overall administration of chiropractic treatment centers. Its business operations are structured into two main divisions: corporate-owned clinics and franchised facilities. The firm employs several strategic models for its expansion and…
Joint stock: price history
1D
+1.7%
1W
-0.1%
1M
-18.5%
6M
-23.8%
YTD
-19.4%
1Y
-15.2%
2Y
-38.7%
5Y
-91.2%
10Y
+171.4%
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~92% stronger price swings than usual
Ask the agents about Joint
Analyst assessment of Joint
PRICE TARGET LOW
US$20.00
CONSENSUS
US$20.00
MEDIAN
US$20.00
PRICE TARGET HIGH
US$20.00
0
STRONG BUY
5
BUY
3
HOLD
0
SELL
0
STRONG SELL
8
TOTAL · Buy
As of: 08/08/2025
Joint stock metrics
P/E
26.5
P/B
6.32
EV/EBITDA
20.61
RETURN ON EQUITY
4.1%
NET MARGIN
4.3%
DEBT/EQUITY
0.13
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
83.8%
FLOAT SHARES
11,847,900
AVG. DAILY VOLUME (30D)
91,629
Insider transactions (SEC)
Bowman Scott Justin
Pant Milind
Rubel Matthew E
Karrmann Sandra R
DaVella Ronald V
Institutional holders
Comparable stocks
Frequently asked questions about Joint stock
What does Joint do?
The Joint Corp. is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in United States.
The CEO is Sanjiv Razdan, the company employs around 330 people.
The IPO was on 11/11/2014; the stock trades on NASDAQ under the ticker JYNT.
What do analysts say about Joint stock?
8 analysts rate the stock, the consensus is Buy (as of 08/08/2025).
The average price target is US$20.00, ranging from US$20.00 to US$20.00, with a median of US$20.00.
This is an external assessment, not a statement by Market Jury.
When does Joint report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 92% stronger than usual.
Does Joint pay a dividend?
No, Joint currently does not pay a dividend.
Which stocks are comparable to Joint?
Comparable stocks include HCA Healthcare, Tenet Healthcare, DaVita, Universal Health Services, Hims & Hers Health, LifeStance Health Group, Concentra Group Holdings Parent and Acadia Healthcare Company.
How can I get Joint stock analyzed?
Clicking "Analyze stock" lets five strategies assess Joint against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.